The KHRC received the post-race test results May 7 from both the Kentucky Oaks (gr. I) and the Kentucky Derby presented by Yum! Brands (gr. I) and all samples have been cleared.
Federal intervention is the only way horse racing can resolve issues surrounding equine medication use, drug testing, and sufficient investigatory programs, said an attorney, also a Kentucky racing commissioner, May 2.
- By Tom LaMarra
As predicted by horsemen earlier this year, members of Congress are again preparing to introduce legislation that would regulate the use of medication in racehorses.
The British Horseracing Authority, in a recap of a hearing into trainer Mahmood Al Zarooni's admitted use of anabolic steroids in some of his racehorses, called it a "deliberate flouting" of the rules of racing.
There will be increased security for several days before the May 4 Kentucky Derby Presented by Yum! Brands (gr. I), Kentucky Horse Racing Commission officials said.
Among the speakers for an April 9 seminar on exercise-induced pulmonary hemorrhage are three trainers, officials announced.
Horses competing in the April 6 Wood Memorial Stakes (gr. I) at Aqueduct Racetrack and the Santa Anita Derby (gr. I) at Santa Anita park will be monitored beginning April 3 as part of enhanced security measures.
- By Tom LaMarra
The horse racing industry is taking a closer look at a relaxant that produces optimum results when administered within a few hours of a race. The prevalence of GABA, a supplement, is open to speculation.
The California Horse Racing Board, citing feed contamination, has dismissed 48 positive tests for zilpaterol, which is used in cattle.
Penn National Gaming Inc. has updated its guide for horsemen to reflect sanctions against those involved with racehorses that test positive for illegal medications.
The regulators of eight states in the Northeast region have committed to a uniform medication and drug testing program in a move supporters believe is a step toward uniform regulation of medication and drug testing.
The West Virginia Racing Commission Feb. 26 approved a resolution agreeing in principle with the effort to bring uniform medication, penalty, and testing rules to racing jurisdictions in the Mid-Atlantic and Northeast.
The National Horsemen's Benevolent and Protective Association Medication Committee voted Feb. 23 to endorse the use of race-day furosemide, also called Salix or Lasix, at this year's Breeders' Cup World Championships.
Horsemen expect members of Congress to make another attempt at winning support for legislation that would regulate medication use in racehorses by banning all race-day administration.
The Maryland Racing Commission voted Feb. 19 to adopt a uniform equine medication, penalty, and testing program proposed for Thoroughbred and Standardbred racetracks throughout the Mid-Atlantic region.
A search committee has been formed to find an equine veterinary medical director for the New York Racing Association.
Industry stakeholders, mostly from the Mid-Atlantic and Northeast, met Feb. 6 in Delaware to examine equine medication policy in an attempt to bring about uniformity from state to state.
A group of scientists met with representatives of the Thoroughbred Owners of California Jan. 18 to discuss exercise-induced pulmonary hemorrhaging and later issued a joint statement supporting use of furosemide.
Legislation calling for a ban on performance-enhancing drugs in horse racing has been sent to the New York Senate Racing, Gaming, and Wagering Committee.
Remington President Scott Wells said the track will use suspension lists provided by major racing organizations to prevent suspended horsemen from participating.
Racing jurisdictions and racetracks are making some headway on tightening the screws on integrity in the sport, though one official Dec. 6 described it as a "minefield" due to legal issues and court fights.
The Racing Medication and Testing Consortium board of directors has approved thresholds and withdrawal guidelines for six medications that have been identified as having therapeutic purposes.
All samples collected from horses that ran in the Breeders' Cup World Championships at Santa Anita Park Nov. 2-3 have been cleared by the Kenneth L. Maddy Equine Analytical Chemistry Laboratory at UC Davis.
Prodded by a rash of equine deaths at Aqueduct Racetrack last winter, the New York State Racing and Wagering Board Oct. 11 imposed what officials promised will be the first round of rules intended to make for safer racing.
New York racing officials are set to begin implementing new rules based on recommendations by a recent industry task force report to increase safety conditions for horses and jockeys.
A task force has determined the spate of fatal racehorse breakdowns at Aqueduct Racetrack this past winter was primarily the result of structural deficiencies in rules and regulations employed by NYRA and racing regulators.
The Kentucky HBPA said Aug. 31 it is "frustrated and extremely disappointed" with the decision by Kentucky Gov. Steve Beshear to override a vote by a legislative committee that found new equine medical rules deficient.
Kentucky Gov. Steve Beshear Aug. 30 said regulations designed to reform some aspects of the state's equine medication policy will be implemented despite action by a legislative committee that found them deficient.
Two more national organizations have called on Kentucky to move forward with medication reform regulations shot down by a legislative committee Aug. 27.
Two national organizations said Aug. 28 they find it "troubling" factions in Kentucky horse racing are opposing medication regulations proposed by the Kentucky Horse Racing Commission but shot down by a legislative committee.
The West Virginia Racing Commission has officially scheduled a meeting for Sept. 17 to take comments from industry representatives on the use of furosemide, also known as Salix or Lasix, on race day.
A Kentucky legislative subcommittee, in a surprise vote, found regulations governing equine medication "deficient" Aug. 27, just one week before they are scheduled to take effect.
Furosemide will be the only medication permitted on race day in Kentucky effective Sept. 4, and the drug will be administered by regulatory veterinarians only under new Kentucky Horse Racing Commission rules.
The Nebraska Racing Commission is investigating a positive test for dermorphin, a Class 1 pain-killer more powerful than morphine.
There may be plenty of data out there on trainer performance, but for owners, selecting a conditioner involves much more than numbers, according to an owner and trainer that have worked together for about 15 years.
The West Virginia Racing Commission in late summer or early fall plans to hold a fact-finding meeting on use of furosemide on race day, officials said Aug. 4.
- By Tom LaMarra
The majority of National Horsemen's Benevolent and Protective Association affiliates have adopted resolutions calling for continued regulated use of furosemide on race day.
- By Tom LaMarra
A new grassroots organization that opposes use of medication on race day wants involvement by the federal government in horse racing.
The Association of Racing Commissioners International is reassessing its policy supporting race-day administration of furosemide, but also indicated much needs to be done before any change is made.
The Jockey Club isn't opposed to federal regulation of medication and penalties in horse racing but it would prefer Congress not tinker with the Interstate Horse Racing Act, an organization official said July 12.
The Racing Medication and Testing Consortium has hired Dr. Dionne Benson as executive director and chief operating officer.
The Kentucky Horse Racing Commission said July 11 no dermorphin, a pain-killer more powerful than morphine, was found in samples tested from some horses that raced in this year's Derby and Oaks.
- By Tom LaMarra
The Thoroughbred Racing Associations has endorsed a policy for medication reform that has been supported by many industry stakeholders but so far acted upon piecemeal in various jurisdictions.
The National HBPA and its affiliates said they have "zero tolerance" for trainers who use illegal Class 1 and Class 2 substances in racehorses in the wake of about 30 positives for Dermorphin in the Southwest.
During an oddly lopsided meeting on a proposal to phase-out use of furosemide on race day in listed and graded stakes in Kentucky, proponents of the therapeutic anti-bleeding medication made their case. But it may not matter.
A Standardbred trainer was suspended in New York May 24 for an alleged 1,700 equine medication violations after a joint investigation by New York and New Jersey regulators.
A new law that allows for an expansion of racetrack card clubs in Minnesota also permits the Minnesota Racing Commission to set threshold testing levels for therapeutic medications used in racehorses.
The racing industry is closer to uniformity in drug regulations and penalties than many admit, but agreement on race-day anti-bleeding drugs in a "toxic" environment will require some heavy lifting, officials said May 2.
A coalition of Pennsylvania horsemen is seeking a series of "state-level" meetings of all stakeholders in horse racing to examine ways to improve the health and safety of equine and human participants.
- By Tom LaMarra
The Jockey Club officially released its "Reformed Racing Medication Rules" March 30, but broad adoption of the policies hinges on action by regulators in all racing jurisdictions.
Most Popular Stories
- Curlin Colt Sells for $350,000 at F-T October
- Cinco Charlie to Spendthrift Farm
- Kentucky Derby Winner Monarchos Dies
- Tapit Colt Late Withdrawal from F-T Sale
- Keen Ice Confirmed for Breeders' Cup Classic
- Malibu Moon Filly Sells for $300,000 at F-T
- Inside the Magical Kingdom of Ballydoyle
- Positive Start to Fasig-Tipton October Sale
- Mike Tirico to Host NBC's Prime BC Coverage
- Arc Winner Found Could Run in BC Classic